Saturday 17 October 2026
Export OPRX’s income statement to Excel — free account
OptimizeRx Corp.
OPRX Healthcare Health Information Services
OptimizeRx Corp.’s revenue for fiscal 2025 (year ended December 2025) was $109.4 million, up 18.8% from fiscal 2024. In the quarter to June 2026, revenue fell 29.8%, EPS fell 150.0%, free cash flow grew 89.9% and total debt fell 33.1%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
8.50
0.35
−3.95%
Follow OPRX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 3.68% | 5.56% | 4.18% | 0.03% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
7 | 8 | 8 | 7 | |
| 2.76% | 4.08% | 2.95% | 0.02% | ||
ROIC |
5.41% | 6.68% | 5.60% | 3.24% | |
Return on Tangible Assets |
10.33% | 14.92% | 11.78% | 0.09% | |
Average Days of Receivables |
100.35 | 111.73 | 128.43 | 113.24 | |
Free Cash Flow per Share |
0.99 | 0.77 | 1.01 | 0.62 | |
Free Cash Flow |
18.57 | 14.52 | 18.78 | 11.57 | |
Capital Expenditures |
0.14 | 0.13 | 0.07 | (0.26) | |
| Other line items | |||||
Cash ROIC |
10.66% | 8.38% | 10.59% | 6.81% | |
Accounts Receivable Turnover |
3.22 | 3.27 | 2.85 | 3.63 | |
Accounts Payable Turnover |
15.99 | 9.98 | 18.90 | 15.86 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
18.28 | 34.80 | 16.66 | 19.57 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.32) | (0.29) | (0.26) | (0.98) | |
Research and Development Expense of Revenue |
13.20% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
57.12% | 52.33% | 52.28% | 49.35% | |
Share Based Compensation of Revenue |
8.06% | 6.74% | 6.36% | 7.25% | |
Interest Coverage |
2.33 | 2.75 | 2.21 | 1.21 | |
Operating CF/Net income |
4.01 | 2.10 | 3.65 | 358.33 | |
Depreciation/Fixed assets |
44.43 | 52.25 | 51.29 | (17.42) | |
Capex/Depreciation |
0.03 | 0.02 | 0.01 | 0.12 | |
Revenue per Share |
5.25 | 5.72 | 5.90 | 5.90 | |
Operating CF per Share |
0.98 | 0.77 | 1.01 | 0.64 | |
Capex per Share |
0.01 | 0.01 | 0.00 | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates